Saroglitazar for the treatment of hypertrig-lyceridemia in patients with type 2 diabetes: current evidence

Diabetes mellitus (DM) is one of the most dreaded metabolic disorders in the world today. It is the leading cause of morbidity and mortality, and plays a cardinal role in quality of life and health economics. DM is associated with a high prevalence of microvascular and macrovascular complications. D...

Descripción completa

Detalles Bibliográficos
Autores principales: Sosale, Aravind, Saboo, Banshi, Sosale, Bhavana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403747/
https://www.ncbi.nlm.nih.gov/pubmed/25926748
http://dx.doi.org/10.2147/DMSO.S49592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403747/
https://www.ncbi.nlm.nih.gov/pubmed/25926748
http://dx.doi.org/10.2147/DMSO.S49592

Ejemplares similares